Drug Supplier Possibly Lied About FDA Docs, Judge Says

Law360, New York (December 17, 2012, 12:48 PM EST) -- A Massachusetts federal judge refused Friday to toss drugmaker Bryan Corp.’s fraud allegations against supplier ChemWerth Inc., saying there’s abundant evidence of potential falsehoods surrounding attempts to satisfy U.S. Food and Drug Administration manufacturing standards.

In rejecting a motion to dismiss, U.S. Magistrate Judge Judith Gail Dein noted that Bryan had cited specific meetings — including dates, attendees and written materials — during which ChemWerth allegedly promised to file all required paperwork with the FDA regarding the China-based production of tobramycin sulfate, which Bryan purchased in...
To view the full article, register now.




Case Information

Case Title

Bryan Corporation v. Chemwerth, Inc.

Case Number




Nature of Suit

Contract: Other


Judith G. Dein

Date Filed

March 8, 2012

Law Firms

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.